PRR30
Proline-rich protein 30
Also known as: C2orf53, MGC44505, PRR30_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53SZ7
- Gene
- PRR30
- Ensembl
- ENSG00000186143
- Chromosome
- 2
- Canonical length
- 412 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for PRR30 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
412 residues, UniProt reviewed canonical sequence.
>Q53SZ7|PRR30
1 MLPQNKDQVL PQTSVLPGRP TWGFSQLVDS SPHNLQPLSP HQGLPPSQPP FSSTQSRRPS
61 SPPPASPSPG FQFGSCDSNS DFAPHPYSPS LPSSPTFFHQ NYLSLPRPRA SSPSNHWLYP
121 SPPLTPSFSP SQPQNSSLPH SPCQSPSHPE ELHSSTLTSP GPSPPSHRLH SNRQTWRWHQ
181 YRDTGSGSPG VVERCVPSEK DPAQFRDPGA LAQALVVQLG HRRIAHDLRL LLLQHLWLGR
241 TGQAPVVEYP ICLVCLRPRS PSCPLPRYRT GPRLLAFPQL LPCVQGQESG PLRIGIGFGL
301 RLPQGQARAL HLLPEKRPKE AGPQGKATQA CGHQLPASQP PAAQARADPV PGTPSQTRSF
361 RSAGLQSPNS PRCFSGPPPR APKQVTTSLK PRPCPGPKRP VSLELILQKS SVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRR30 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 138 nTPM
Expression across tissuesHPA
Tissue
- testis: 138 nTPM
- prostate: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- late spermatids: 1,334 nCPM
- early spermatids: 717 nCPM
- late primary spermatocytes: 252 nCPM
- leydig cells: 2.9 nCPM
- early primary spermatocytes: 1.8 nCPM
- peritubular myoid cells: 1.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.3 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Protein of unknown function DUF4679
- Domain of unknown function (DUF4679)
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRR30 as an antibody target. Whether an autoantibody or antibody against PRR30 could matter depends on whether native PRR30 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRR30 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRR30 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...